Abstract
Baseline Hypoalbuminemia Does Not Appear to be an Adverse Prognostic Factor in Patients with Relapse/Refractory B-Cell Lymphomas Treated with Axicabtagene Ciloleucel (axi-cel)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have